Nurix Therapeutics Fiscal Q3 Net Loss Narrows, Revenue Falls-January 2024-www.financetom.com

Nurix Therapeutics Fiscal Q3 Net Loss Narrows, Revenue Falls

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nurix Therapeutics Fiscal Q3 Net Loss Narrows, Revenue Falls

Oct 11, 2024 1:49 PM

04:21 PM EDT, 10/11/2024 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported Friday a fiscal Q3 net loss of $0.67 per diluted share, narrower than a loss of $0.68 a year ago.

Analysts polled by Capital IQ expected a loss of $0.71 per share.

Revenue for the quarter ended Aug. 31 was $12.6 million, down from $18.5 million a year earlier.

Analysts surveyed by Capital IQ expected $12.3 million.

Price: 23.57, Change: -0.06, Percent Change: -0.25

Previous page： -- RBC Brief: "In turn, we view the situation as idiosyncratic and expect balance of 2025 credit performance to be more consistent with RY's guidance," adds National Bank Next page： -- RBC Brief: "While these numbers certainly stand out, they were attributable almost entirely to a single credit exposure for which the bank had pre-provisioned," says National Bank

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

-- RBC Brief: "In turn, we view the situation as idiosyncratic and expect balance of 2025 credit performance to be more consistent with RY's guidance," adds National Bank

Feb 27, 2025

02:55 PM EST, 02/27/2025 (MT Newswires) -- Price: 166.98, Change: -4.44, Percent Change: -2.59 ...

-- RBC Brief: "While these numbers certainly stand out, they were attributable almost entirely to a single credit exposure for which the bank had pre-provisioned," says National Bank

Feb 27, 2025

02:53 PM EST, 02/27/2025 (MT Newswires) -- Price: 167.04, Change: -4.38, Percent Change: -2.56 ...

-- RBC Brief: National Bank Notes Q1 Results met with negative reaction, due to 27% negative deviation against PCL forecasts (and a commensurate 34% Q/Q lift in impaired loan balances)

Feb 27, 2025

02:52 PM EST, 02/27/2025 (MT Newswires) -- Price: 167.17, Change: -4.25, Percent Change: -2.48 ...

Westamerica Bancorporation Reports Stock Buyback Plan

Feb 27, 2025

03:01 PM EST, 02/27/2025 (MT Newswires) -- Westamerica Bancorporation (WABC) said Thursday its board has approved a plan to repurchase up to 2 million shares before March 31, 2026. The repurchase plan represents about 7.5% of its outstanding shares, the company said. Price: 51.43, Change: +1.29, Percent Change: +2.57 ...